吞噬作用
小胶质细胞
病理
髓鞘
中枢神经系统
生物
病变
巨噬细胞
神经胶质
血管周围间隙
细胞
细胞生物学
炎症
脊髓损伤
医学
周细胞
免疫学
神经炎症
电池类型
神经科学
冲程(发动机)
胶质瘢痕
纤维化
泡沫电池
吞噬细胞
脊髓
作者
Tian Zhou,Zhenwei Zhang,Fanzhuo Zeng,Hao Song,Zhen Xu,Zhenyu Hu,Luming Yao,Wanying Wang,Tianlei Zhang,Xiaoyan Du,Kexiang Li,Zaichao Xie,Yu Sun,Baiqing Ren,Benji Fan,Shaoda Qi,Ying Li,Yifan Hu,Miao Huang,Yutong Chen
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2026-08-09
标识
DOI:10.64898/2026.08.03.742479
摘要
Abstract Injury, stroke, and neurological diseases cause persistent accumulation of cellular debris that deteriorates lesion microenvironment and impedes central nervous system (CNS) repair. Debris clearance in the injured CNS has long been attributed primarily to microglia and infiltrating macrophages. Here, we identify perivascular cells as previously unrecognized phagocytes that expand after injury and exhibit robust phagocytic activity. Perivascular cell phagocytosis is conserved across multiple mouse models of CNS injury and human stroke lesions. These cells exhibit key hallmarks of phagocytosis, including LC3-associated phagocytosis for efficient lysosomal degradation. Mechanistically, phosphatidylserine serves as the ‘eat-me’ signal and Axl mediates myelin debris uptake. Myelin phagocytosis drives perivascular cell proliferation, fibrosis and lesion progression. Genetic deletion of Axl in perivascular cells or pharmacological inhibition with the FDA-approved Axl inhibitor Gilteritinib reduces pathology and improves functional recovery after spinal cord injury. Together, these findings establish Axl-dependent perivascular cell phagocytosis as a therapeutic target for CNS repair.
科研通智能强力驱动
Strongly Powered by AbleSci AI